World News

New on NCI’s Websites for December 2023

Ogkologos - 28 Δεκεμβρίου, 2023

How Early Cancer Detection and Diagnosis Saved My Life Twice: A...

Ogkologos - 27 Δεκεμβρίου, 2023

Honoring Other’s Wishes

Ogkologos - 22 Δεκεμβρίου, 2023

Following Abnormal Cancer Screening Results, Multi-Level Reminders May Increase Follow-Up

Ogkologos - 22 Δεκεμβρίου, 2023

What to Know About Using Activated Charcoal During Cancer

Ogkologos - 21 Δεκεμβρίου, 2023

Genetic Signature May Help Tailor Treatment for Meningioma

Ogkologos - 21 Δεκεμβρίου, 2023

Mosunetuzumab Plus Polatuzumab Vedotin Shows Promise for Patients with Aggressive Relapsed...

Ogkologos - 21 Δεκεμβρίου, 2023

Oligoprogression in Metastatic NSCLC Could Be Effectively Treated with SBRT Plus...

Ogkologos - 21 Δεκεμβρίου, 2023

Surprise! Financial Assistance To Help With Your Medical Bills May Be...

Ogkologos - 20 Δεκεμβρίου, 2023

Holidays and Hope When a Loved One Has Advanced Cancer

Ogkologos - 20 Δεκεμβρίου, 2023

1...979899...432 Σελίδα 98 από 432

MOST POPULAR

Encouraging Antitumour Activity of First-Line Atezolizumab Plus Paclitaxel and Bevacizumab in...

16 Ιουλίου, 2025

EMA Recommends Extension of Indications for Serplulimab

22 Απριλίου, 2026

Easy Meals at Home

23 Οκτωβρίου, 2020

Adjuvant Capecitabine-Containing Regimen Improves Modestly Overall Survival in Patients with Early...

18 Ιανουαρίου, 2022

Φόρτωση περισσοτέρων

New on NCI’s Websites for December 2023

How Early Cancer Detection and Diagnosis Saved My Life Twice: A...

Honoring Other’s Wishes

Following Abnormal Cancer Screening Results, Multi-Level Reminders May Increase Follow-Up

What to Know About Using Activated Charcoal During Cancer

Genetic Signature May Help Tailor Treatment for Meningioma

Mosunetuzumab Plus Polatuzumab Vedotin Shows Promise for Patients with Aggressive Relapsed...

Oligoprogression in Metastatic NSCLC Could Be Effectively Treated with SBRT Plus...

Surprise! Financial Assistance To Help With Your Medical Bills May Be...

Holidays and Hope When a Loved One Has Advanced Cancer

MOST POPULAR

Encouraging Antitumour Activity of First-Line Atezolizumab Plus Paclitaxel and Bevacizumab in...

EMA Recommends Extension of Indications for Serplulimab

Easy Meals at Home

Adjuvant Capecitabine-Containing Regimen Improves Modestly Overall Survival in Patients with Early...

HOT NEWS

Sacituzumab Govitecan Demonstrates Overall Survival Benefit Over Chemotherapy in Patients with...

20 years on: how we’ve decreased cancer death rates

At 3-Year Follow-Up Nivolumab Plus Chemotherapy Continued to Demonstrate OS Improvement...

Cancer research in 2020: A spotlight on Manchester

ΔΗΜΟΦΙΛΕΊΣ ΘΈΣΕΙΣ

ΚΑΡΚΙΝΟΣ ΘΥΜΟΥ ΑΔΕΝΑ (ΘΥΜΩΜΑ)

ΣΤΑΤΙΣΤΙΚΑ

ΚΕΝΤΡΙΚΟΥ ΝΕΥΡΙΚΟΥ ΣΥΣΤΗΜΑΤΟΣ

ΔΗΜΟΦΙΛΗ ΚΑΤΗΓΟΡΙΑ